Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Comparison of patient-reported ratings to those of caregiver proxies in a 12-week open-label trial (PRISM II)

Rachelle S Doody, Andrew J Cutler + Show 5 more

Open Access

https://doi.org/10.1016/j.jalz.2015.06.501

Copy DOI

Journal: Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Publication Date: Jul 1, 2015

Affiliation: Baylor College of Medicine, Meridien Research, Avanir Pharmaceuticals (United States)

#Pseudobulbar Affect #12-week Trial + Show 3 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Comparison of patient-reported ratings to those of caregiver proxies in a 12-week open-label trial (PRISM II)

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export